Antiacne Medications Pseudotumor Cerebri
- Conditions
- Optic Disc Swelling
- Interventions
- Other: Retinal nerve fibre layer measurement
- Registration Number
- NCT02149615
- Lead Sponsor
- University of Zurich
- Brief Summary
The exact incidence of optic disc swelling and idiopathic intracranial hypertension in patients using antiacne medication is not known so far. The investigators hypothesize that swelling of retinal nerve fibre layer measured by optical coherence tomography is more frequent then assumed so far.
- Detailed Description
Measurement of retinal nerve fibre layer using optical coherence tomography over a period of 6 to 9 months depending on exact antiacne medication.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 310
- Antiacne medication treatment indicated by dermatologist
- age > 18 years
- contraception if indicated
- age < 18 years
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description isotretinoin Retinal nerve fibre layer measurement Retinal nerve fibre layer measurement in patients under isotretinoin treatment lymecycline Retinal nerve fibre layer measurement Retinal nerve fibre layer measurement in patients under lymecycline treatment minocycline Retinal nerve fibre layer measurement Retinal nerve fibre layer measurement in patients under minocycline treatment doxycycline Retinal nerve fibre layer measurement Retinal nerve fibre layer measurement in patients under doxycycline treatment
- Primary Outcome Measures
Name Time Method Retinal nerve fibre layer 9 months Measurement of retinal nerve fibre layer using optical coherence tomography. Changes over 10 micrometers are considered to be clinically relevant.
The Term "retinal nerve fibre layer" describes an automated standardized optical coherence tomography measurement program measuring the sectorial thickness of the peripapillar retinal nerve fibre layer. There exists no other term for that.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Hospital Zurich
🇨ðŸ‡Zurich, ZH, Switzerland